Who we are
The M4PM project is led by Space Applications Services and co-financed by the European Space Agency. In this endeavour, we have partnered with OrganoTherapeutics in the role of pilot customer, aiming for a demo mission in late 2026.
M4PM Partners
Space Applications Services (SpaceApps) is an independent Belgium-based company founded in 1987, with offices in Europe (Belgium and the Netherlands) and a subsidiary, Aerospace Applications North America, in Houston, Texas (USA). With a strong focus on R&D, the company collaborates with global partners to develop innovative products, sys
Space Applications Services (SpaceApps) is an independent Belgium-based company founded in 1987, with offices in Europe (Belgium and the Netherlands) and a subsidiary, Aerospace Applications North America, in Houston, Texas (USA). With a strong focus on R&D, the company collaborates with global partners to develop innovative products, systems and solutions, while providing services to the aerospace and security markets and related industries. The company’s expertise spans various segments, including robotics and AI, flight and ground systems, crewed and autonomous spacecraft, mission control centers and information systems, payload integration and operations.
Through the ICE Cubes Service, Space Applications Services provides fast, direct and affordable access to space for research, technology and education, on a commercial basis. The end-to-end service facilitates a frequent and regular ‘launch-and-return’ capability to/from the International Space Station, and offers a unique real-time inter
Through the ICE Cubes Service, Space Applications Services provides fast, direct and affordable access to space for research, technology and education, on a commercial basis. The end-to-end service facilitates a frequent and regular ‘launch-and-return’ capability to/from the International Space Station, and offers a unique real-time interaction capability. To date, over 35 payloads, devices and experiments have been successfully flown to the ISS, and operated on board the station. Key markets include health and life sciences, materials, agrifood, and technology.
The European Space Agency (ESA) is Europe’s gateway to space, dedicated to the peaceful exploration and use of space for the benefit of all. With 22 Member States, ESA develops and implements space missions and technologies across a wide range of domains, including Earth observation, human spaceflight, telecommunications, and scientific r
The European Space Agency (ESA) is Europe’s gateway to space, dedicated to the peaceful exploration and use of space for the benefit of all. With 22 Member States, ESA develops and implements space missions and technologies across a wide range of domains, including Earth observation, human spaceflight, telecommunications, and scientific research. ESA fosters innovation and international collaboration, supporting cutting-edge projects that advance knowledge, drive economic growth, and improve life on Earth.
M4PM Pilot Customer
OrganoTherapeutics SARL (OT) is a spin-off company from the University of Luxembourg. OT use innovative human brain organoids for the discovery and development of effective drug candidates targeting Parkinson’s disease (PD). OT screens for novel compounds which can be therapeutic for different patient groups, with the mission to accelerate the development of therapeutics against neurodegeneration. M4PM’s first mission will focus on Parkinson’s disease, with OrganoTherapeutics as the pilot customer, studying midbrain organoids. Their goal is to develop a more accurate disease model and uncover new treatment insights.